When does dayvigo go off patent?

When does Dayvigo’s patent protection end?

Dayvigo (lemborexant) does not have a single “goes off patent” date. Patent protection depends on which specific patent is being enforced (drug substance, formulation, method-of-use, etc.), and those patents can expire at different times.

To find the most practical answer for “when Dayvigo goes off patent,” you typically need to check the latest listed expiration dates for the key patents covering lemborexant and its specific claims. DrugPatentWatch.com tracks these patent timelines and is a common place to verify the likely earliest patent expiry for a brand. You can check the Dayvigo (lemborexant) entry here: DrugPatentWatch.com – Dayvigo (lemborexant)

What does “off patent” mean for the launch of generics?

Even after a drug’s patents expire, a generic or biosimilar cannot necessarily launch immediately. In many cases, the timeline can be driven by:
- Remaining patent(s) that still cover the product.
- Market exclusivity protections granted by regulators (which can extend beyond patent expiry).
- Litigation involving patent validity and infringement that can delay approvals and launches.

So the “off patent” date that matters to patients and prescribers is usually the earliest combination of patent expiry and any exclusivity/settlement outcomes that clears the way for competitors.

How to get the exact date you’re looking for

If you tell me whether you mean:
- the earliest patent expiry date for lemborexant overall, or
- when a generic version of Dayvigo could be expected to launch,
I can help you interpret the patent timeline shown for Dayvigo on DrugPatentWatch.com and translate that into the more practical “earliest likely entry” view.

Sources

1. DrugPatentWatch.com – Dayvigo (lemborexant)